Delivery Order SPE2DB22D1202-SPE2DB25FVBR7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a $2,871.10 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of June 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $7,213.88. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $81,684.20 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price, non-set-aside delivery order executed under a competitive procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,265.45 on October 15, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This non-competitive delivery order is a firm fixed price contract with a completion date of October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,770.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside provisions and is classified as a firm fixed price delivery order, with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) with a contract ceiling value of $3,766.98. This non-set-aside, firm fixed-price delivery order was competitively awarded on May 20, 2025, with an ultimate completion date of May 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $8,586.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $8,858.64 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVBR7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,518.37 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (quantity: 30 units). The contract, executed on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX vehicle functions as a comprehensive global pharmaceutical support contract enabling the supply of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The firm has demonstrated capability to fulfill federal procurement requirements through competitive bidding, with its contract portfolio encompassing specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains. This award supports the Defense Health Agency and other government healthcare systems' pharmaceutical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 6/6/25 |